<DOC>
	<DOCNO>NCT03064620</DOCNO>
	<brief_summary>Objective : PCV effect S. pneumoniae S. aureus carriage population base study . The major specific aim : 1 . To compare different PCV vaccination policy , cross-sectional repeat surveillance closely related population live region different vaccination policy . 2 . To compare epidemiology , predictor outcomes antibiotic resistant S. aureus S. pneumoniae different region PICR . Study design : Annual / Biannual cross-sectional surveillance nasal S. aureus carriage nasopharyngeal S. pneumoniae carriage child one parent .</brief_summary>
	<brief_title>PICR-b Nasopharyngeal S. Pneumoniae Nasal S. Aureus Carriage Study</brief_title>
	<detailed_description>Study design : Annual / Biannual cross-sectional surveillance nasal S. aureus carriage nasopharyngeal S. pneumoniae carriage child one parent . PICR district : 1 . Palestinian Authority ( PA ) - particularly : Bethlehem , Ramallah Nabulus . 2 . East Jerusalem ( EJ ) 3 . Central Israel ( IL ) - particularly : Rishon Lezion , Bat Yam , Holon 4 . Gaza strip ( GZ ) - 12 region include cities/villages central/northern Gaza . Study population : Child ( age 0-5y ) &amp; Parent attend clinic ( reason ) . Exclusion criterion : Parent agree sign inform consent Child sibling ( brother/sister ) already participate . Both healthy ill child screen . No specific exclusion . Only one child per family ( young child , one available ) one parent ( mother , available ) . Sample size per year : IL : Central Israel ( Hashfela District ) : 400 pair child+parent/surveillance EJ : East Jerusalem : 400 pair child+parent/surveillance PA : West Bank city ( Ramallah , Bethlehem &amp; Nabulus ) : 600 pair child+parent/surveillance GZ : Gaza strip : 300 pair child+parent/surveillance Study Period : May-August annually 2009 - 2011 - ( Part ) . May-August biannually 2014-2016-2018-2020 Current study ( Part b ) . Screening Procedure : 1 . Parent sign inform consent 2 . Put Barcode sticker inform consent , questionnaire , swabs daily list 3 . Fill questionnaire parent . 4 . Fill physician questionnaire 5 . Nasal &amp; nasopharyngeal swab child parent . 6 . Fill daily work table . 7 . Write number refusal ( parent refuse ) daily table . 8 . Fill questionnaire FULLY ( unmarked question analyze ) - put x question - whether YES NO . Swabbing : 1 . First swab child follow parent . 2 . First perform nasal swab ( S. aureus ) use cotton-tip swab place Amies transport Media ( Blue ) follow nasopharyngeal swab ( S. pneumoniae ) use rayon-tipped aluminum shaft swab place Amies transport Media ( Orange ) . 3 . Slightly wet nasal swab sterile saline . Swab anterior naris . 4 . Nasopharyngeal swab one nostril - gently , quickly deep nasopharynx - touch nasopharyngeal wall . Swab transfer lab : If swab store overnight transfer - keep 40C ( fridge ) . Within 24h swab must reach central laboratory ( Dr. Regev-Yochay 's Lab Sheba Medical Center ) .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<criteria>Any child young 5 year , visit participate clinic surveillance period Older 5 year Previously participate study . Sibling participate study . Parent agree sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PCV effect</keyword>
	<keyword>S. pneumoniae carriage</keyword>
	<keyword>S. aureus carriage</keyword>
	<keyword>Indirect vaccination effect</keyword>
	<keyword>Palestinian-Israeli Collaborative Research ( PICR )</keyword>
</DOC>